Brawn Biotech Limited announced earnings results for the fourth quarter ended March 31, 2020. For the fourth quarter, the company announced total revenue was INR 67.752 million compared to INR 160.573 million a year ago. Operating loss was INR 3.827 million compared to operating Income of INR 3.600 million a year ago. Net loss was INR 3.227 million compared to net income of INR 3.049 million a year ago. Basic loss per share was INR 0.8 compared to basic earnings per share of INR 1.02 a year ago. For the full year, total revenue was INR 497.871 million compared to INR 659.168 million a year ago. Operating income was INR 8.197 million compared to INR 18.054 million a year ago. Net income was INR 5.913 million compared to INR 13.329 million a year ago. Basic earnings per share was INR 2.01 compared to INR 4.63 a year ago.